REGULATORY SUBMISSION AND VALIDATION PROCESS FOR MODERNA'S SEASONAL INFLUENZA VACCINE

NOTICE PAPER NO. 565

NOTICE OF QUESTION FOR ORAL ANSWER

FOR THE SITTING OF PARLIAMENT ON 2 MARCH 2026

Name and Constituency of Member of Parliament

Mr Yip Hon Weng

MP for Yio Chu Kang

Question No. 1656

To ask the Coordinating Minister for Social Policies and Minister for Health (a) whether the Health Sciences Authority (HSA) has received a recent submission for Moderna’s mRNA influenza vaccine; and (b) to what extent Singapore’s safety and efficacy validation process remains independent of the US and European standards.

Answer

1                    The Health Sciences Authority (HSA) has not received any regulatory submission for Moderna’s mRNA seasonal influenza vaccine.

2                    HSA always exercises its regulatory authority independently. But, that said, in the healthcare regulatory world, there are many collaborations and partnerships; highly regarded regulatory bodies become references for others; just as Singapore is a reference for others and we also reference other highly reputable jurisdictions.